A major concern during the M&A process is whether the bought-out company's available/ongoing/planned clinical studies are designed to meet the target's average sales price and market penetration projections. This means have to demonstrate your product value and validating it with clinical efficacy statistics, real-world data, patient quality of life reports, etc.
Start-up founders and entrepreneurs can stay ahead of the game by registering for this webinar and learn how to optimise their clinical operation knowledge and clearly and succinctly communicate the value of their innovations to stakeholders.
[Founders Series by APACMed] Clinical Trials & Strategy - Turbo Boosting Adoption & Approval
Date: Wednesday, 10 June 2020
Time: 3pm to 4pm (Singapore Time)
This webinar is part of a series of events and webinars for the Founders Series - a programme curated by APACMed to give young start-ups the opportunity to sit at the same table with key stakeholders in the healthcare ecosystem as they receive support, mentorship and guidance from industry leaders.
Please note that this webinar is exclusive to APACMed members only and Founders Series participants only. Login details will be shared via email with those who have registered for the event, closer to the event date.
If you are a start-up and interested to find out more about the Founders Series and how you can participate in it, please email Gabriel Sim, Director of Strategic Partnerships, at firstname.lastname@example.org.
Jun 10, 2020
3:00 PM - 4:00 PM (GMT+8)